Pollock Colleen M, Campbell John R, Rousseau Marjolaine, Windeyer M Claire, Waldner Cheryl L
Department of Large Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4 (Pollock, Campbell, Waldner); Département de Sciences Cliniques, Faculté de Médecine Vétérinaire, Université de Montréal, 3200 Rue Sicotte, Saint-Hyacinthe, Quebec J2S 2M2 (Rousseau); Faculty of Veterinary Medicine, University of Calgary, 11877 85 Street NW, Calgary, Alberta T3R 1J3 (Windeyer).
Can Vet J. 2025 May;66(5):555-563.
To estimate the prevalence of bovine viral diarrhea virus (BVDV) infection in spring-born beef calves, at or near fall weaning, and assess how concentrations of BVDV Type 1 and Type 2 antibodies near weaning varied among BVDV vaccination programs.
Serum was collected from 1934 beef calves in 107 herds in the Canadian Cow-Calf Surveillance Network (C3SN).
Reverse transcription real-time polymerase chain reaction was used to detect BVDV infection, and serum virus neutralization assay measured antibody concentrations for BVDV Type 1 and Type 2. Records of BVDV vaccine use were available for nursing calves and cows within the past year from 95 herds. Mixed regression was used to estimate the association between herd vaccination status and antibody concentrations.
Overall, 0.2% of calves and 2.8% of herds were positive or suspect for current BVDV infection. Median serum virus neutralization BVDV Types 1 and 2 titers were 54 and 108, and 19% of calves had undetectable titers. One in 3 calves had titers ≥ 324 and < 6% had titers ≥ 8748. In the 95% of herds in which cows had been vaccinated against BVDV, calves that received 1 or 2 doses of BVDV vaccine pre-weaning (80%) were more likely ( < 0.02) to have BVDV Types 1 and 2 titers ≥ 324 near weaning compared to unvaccinated calves.
Although the overall low prevalence of persistently infected calves was similar to that in previous reports, BVDV antibody titers were higher and the herd-level prevalence of BVDV infection was lower than in previous reports. Herd-level prevalence of BVDV infection was lower in Canadian beef herds that commonly administered BVDV vaccination to both cows and nursing calves. Calves from vaccinated herds also had significantly higher BVDV Type 1 and Type 2 titers at weaning, suggesting reduced risk from transient infection.
评估秋季断奶时或接近秋季断奶时春季出生的肉牛犊牛感染牛病毒性腹泻病毒(BVDV)的患病率,并评估不同BVDV疫苗接种方案下断奶时1型和2型BVDV抗体浓度的差异情况。
从加拿大母牛-犊牛监测网络(C3SN)的107个牛群中的1934头肉牛犊牛采集血清。
采用逆转录实时聚合酶链反应检测BVDV感染情况,血清病毒中和试验测定1型和2型BVDV的抗体浓度。95个牛群提供了过去一年中哺乳犊牛和母牛使用BVDV疫苗的记录。采用混合回归分析评估牛群疫苗接种状态与抗体浓度之间的关联。
总体而言,0.2%的犊牛和2.8%的牛群当前BVDV感染呈阳性或疑似阳性。1型和2型BVDV血清病毒中和滴度中位数分别为54和108,19%的犊牛滴度检测不到。三分之一的犊牛滴度≥324,不到6%的犊牛滴度≥8748。在95%的母牛接种过BVDV疫苗的牛群中,断奶前接受1或2剂BVDV疫苗的犊牛(80%)与未接种疫苗的犊牛相比,断奶时1型和2型BVDV滴度≥324的可能性更高(<0.02)。
尽管持续感染犊牛的总体低患病率与既往报道相似,但BVDV抗体滴度更高,且BVDV感染的牛群水平患病率低于既往报道。在加拿大肉牛群中,通常对母牛和哺乳犊牛都进行BVDV疫苗接种,其BVDV感染的牛群水平患病率较低。来自接种疫苗牛群的犊牛在断奶时1型和2型BVDV滴度也显著更高,表明短暂感染风险降低。